Cargando…
Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public
Researchers have iterated that the future of synthetic biology and biotechnology lies in novel consumer applications of crossing biology with engineering. However, if the new biology’s future is to be sustainable, early and serious efforts must be made towards social sustainability. Therefore, the c...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129221/ https://www.ncbi.nlm.nih.gov/pubmed/25152775 http://dx.doi.org/10.1007/s11569-014-0198-6 |
_version_ | 1782330219550474240 |
---|---|
author | Dankel, Dorothy J. Roland, Kenneth L. Fisher, Michael Brenneman, Karen Delgado, Ana Santander, Javier Baek, Chang-Ho Clark-Curtiss, Josephine Strand, Roger Curtiss, Roy |
author_facet | Dankel, Dorothy J. Roland, Kenneth L. Fisher, Michael Brenneman, Karen Delgado, Ana Santander, Javier Baek, Chang-Ho Clark-Curtiss, Josephine Strand, Roger Curtiss, Roy |
author_sort | Dankel, Dorothy J. |
collection | PubMed |
description | Researchers have iterated that the future of synthetic biology and biotechnology lies in novel consumer applications of crossing biology with engineering. However, if the new biology’s future is to be sustainable, early and serious efforts must be made towards social sustainability. Therefore, the crux of new applications of synthetic biology and biotechnology is public understanding and acceptance. The RASVaccine is a novel recombinant design not found in nature that re-engineers a common bacteria (Salmonella) to produce a strong immune response in humans. Synthesis of the RASVaccine has the potential to improve public health as an inexpensive, non-injectable product. But how can scientists move forward to create a dialogue of creating a ‘common sense’ of this new technology in order to promote social sustainability? This paper delves into public issues raised around these novel technologies and uses the RASVaccine as an example of meeting the public with a common sense of its possibilities and limitations. |
format | Online Article Text |
id | pubmed-4129221 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-41292212014-08-21 Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public Dankel, Dorothy J. Roland, Kenneth L. Fisher, Michael Brenneman, Karen Delgado, Ana Santander, Javier Baek, Chang-Ho Clark-Curtiss, Josephine Strand, Roger Curtiss, Roy Nanoethics Original Paper Researchers have iterated that the future of synthetic biology and biotechnology lies in novel consumer applications of crossing biology with engineering. However, if the new biology’s future is to be sustainable, early and serious efforts must be made towards social sustainability. Therefore, the crux of new applications of synthetic biology and biotechnology is public understanding and acceptance. The RASVaccine is a novel recombinant design not found in nature that re-engineers a common bacteria (Salmonella) to produce a strong immune response in humans. Synthesis of the RASVaccine has the potential to improve public health as an inexpensive, non-injectable product. But how can scientists move forward to create a dialogue of creating a ‘common sense’ of this new technology in order to promote social sustainability? This paper delves into public issues raised around these novel technologies and uses the RASVaccine as an example of meeting the public with a common sense of its possibilities and limitations. Springer Netherlands 2014-07-10 2014 /pmc/articles/PMC4129221/ /pubmed/25152775 http://dx.doi.org/10.1007/s11569-014-0198-6 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Original Paper Dankel, Dorothy J. Roland, Kenneth L. Fisher, Michael Brenneman, Karen Delgado, Ana Santander, Javier Baek, Chang-Ho Clark-Curtiss, Josephine Strand, Roger Curtiss, Roy Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public |
title | Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public |
title_full | Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public |
title_fullStr | Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public |
title_full_unstemmed | Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public |
title_short | Making Common Sense of Vaccines: An Example of Discussing the Recombinant Attenuated Salmonella Vaccine with the Public |
title_sort | making common sense of vaccines: an example of discussing the recombinant attenuated salmonella vaccine with the public |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4129221/ https://www.ncbi.nlm.nih.gov/pubmed/25152775 http://dx.doi.org/10.1007/s11569-014-0198-6 |
work_keys_str_mv | AT dankeldorothyj makingcommonsenseofvaccinesanexampleofdiscussingtherecombinantattenuatedsalmonellavaccinewiththepublic AT rolandkennethl makingcommonsenseofvaccinesanexampleofdiscussingtherecombinantattenuatedsalmonellavaccinewiththepublic AT fishermichael makingcommonsenseofvaccinesanexampleofdiscussingtherecombinantattenuatedsalmonellavaccinewiththepublic AT brennemankaren makingcommonsenseofvaccinesanexampleofdiscussingtherecombinantattenuatedsalmonellavaccinewiththepublic AT delgadoana makingcommonsenseofvaccinesanexampleofdiscussingtherecombinantattenuatedsalmonellavaccinewiththepublic AT santanderjavier makingcommonsenseofvaccinesanexampleofdiscussingtherecombinantattenuatedsalmonellavaccinewiththepublic AT baekchangho makingcommonsenseofvaccinesanexampleofdiscussingtherecombinantattenuatedsalmonellavaccinewiththepublic AT clarkcurtissjosephine makingcommonsenseofvaccinesanexampleofdiscussingtherecombinantattenuatedsalmonellavaccinewiththepublic AT strandroger makingcommonsenseofvaccinesanexampleofdiscussingtherecombinantattenuatedsalmonellavaccinewiththepublic AT curtissroy makingcommonsenseofvaccinesanexampleofdiscussingtherecombinantattenuatedsalmonellavaccinewiththepublic |